Revaccination against coronavirus after a vaccination cycle with a drug developed by the Vector Research Center will be required no more than once every three years. This was stated by the head of the Center for Virology and Biotechnology “Vector” Rinat Maksyutov on September 24.
“After the vaccination cycle, the next revaccination will be required no more than once every three years,” he said in an interview with Naila Askerzade, a fragment of which was posted on her Instagram.
Earlier, on September 23, Russian President Vladimir Putin announced the imminent appearance in Russia of the second vaccine against coronavirus, the developer of which, however, he did not specify.
The world’s first vaccine against coronavirus was developed by specialists of the Russian Research Center of Epidemiology and Microbiology named after N.F. Gamaleya and called “Sputnik V”, it was registered on August 11.
Rospotrebnadzor reported that the registration of another vaccine developed by the Vector Center – EpiVacCorona – is scheduled to be completed by October 15. Further, at the end of October, post-registration studies of the vaccine will begin, in which 5 thousand volunteers will take part – 3 thousand of them will be vaccinated, and 2 thousand will receive a placebo.
As it became known on September 3, all nine volunteers who received the EpiVacCorona vaccine developed antibodies. On the same day, all subjects were discharged from the hospital, noting that they were feeling well and not having any complaints.
According to Ilnaz Imatdinov, a leading researcher at Vector, the first batch of the drug developed by Vector will be released in November.
The first results of vaccine trials will appear in the public domain in the coming months.